Problem
Drug development costs money but there is public disagreement regarding who should pick up the bill. For pharmaceutical companies to develop new drugs, they must generate revenue with current drug patents. Should the government restrict profit margins in this industry vs. others and what would the implications be for novel drug development? What is the alternative? Should we reduce R&D in the field of pharmacology?